Clinical trial
Predictors of the Response to Adalimumab in Rheumatoid Arthritis
NCT00234234 · University Hospital, Rouen, Other · Completed
Key facts
| NCT number | NCT00234234 |
|---|---|
| Title | Predictors of the Response to Adalimumab in Rheumatoid Arthritis |
| Official title | Predictors of the Response to Adalimumab in Rheumatoid Arthritis |
| Lead sponsor | University Hospital, Rouen, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Adalimumab |
| Enrollment | 200 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Oct 6, 2005 |
| Last update posted | Feb 9, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: